SCHEMBL14153055

SCHEMBL14153055

N/C(=N\O)c1ccc(-c2cccc(F)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ CHEK2 O96017 1/20 0.46
▸ HPGDS O60760 1/20 0.44
▸ PTPN1 P18031 1/20 0.43
▸ KDM1A O60341 3/20 0.42
▸ PKM P14618 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ NQO2 P16083 1/20 0.42
▸ CYP17A1 P05093 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GRIN2B Q13224 1/20 0.40
▸ MGLL Q99685 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153514 0.85 TAAR1 (0.53) TAAR1ESR2CHEK2HPGDSPTPN1
SCHEMBL14153243 0.81 ALOX5 (0.51) CHEK2PTPN1KDM1APKMALDH1A1
SCHEMBL31137909 0.80 CYP11B2 (0.46) TAAR1ESR2CHEK2HPGDSKDM1A
SCHEMBL102455 0.80 PARP1 (0.59) KDM1APKMPARP1MEN1ALDH1A1
SCHEMBL102454 0.80 PARP1 (0.59) KDM1APKMPARP1MEN1ALDH1A1
SCHEMBL1009422 0.79 GRIN2B (0.58) TAAR1KDM1ACYP3A4MEN1ALDH1A1
SCHEMBL1009423 0.79 GRIN2B (0.58) TAAR1KDM1ACYP3A4MEN1ALDH1A1
SCHEMBL10092621 0.79 KDM1A (0.54) KDM1AMEN1ALDH1A1KMT2AGRIN2B
SCHEMBL15547657 0.79 CHEK2 (0.67) TAAR1ESR2CHEK2HPGDSPTPN1
SCHEMBL30958375 0.79 CHEK2 (0.67) TAAR1ESR2CHEK2HPGDSPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 — — WO disclosed
Send feedback